VEGF/KDR Signaling in Airway Epithelial Regeneration and Disease

气道上皮再生和疾病中的 VEGF/KDR 信号转导

基本信息

  • 批准号:
    10352400
  • 负责人:
  • 金额:
    $ 49.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-03-01 至 2025-02-28
  • 项目状态:
    未结题

项目摘要

ABSTRACT Mucous metaplasia is commonly associated with morbidity and mortality in multiple lung diseases including fibrosis, COPD and asthma. However, the cellular and molecular mechanisms leading to mucous metaplasia in these diseases remain largely unknown. Recent lineage tracing data suggest that club cells are the cell of origin for metaplastic mucous epithelium. However, the club cell is a heterogenous population, and it remains unknown which club cell subpopulation(s) contribute to mucous metaplasia. Moreover, the molecular mechanisms leading to mucous cell differentiation are largely undetermined. We aim to address these outstanding issues in this proposal. Our single-cell RNA sequencing analysis identified three club cell subpopulations, two of which are characterized by the expression of VEGF receptor 2 (also known as Flk1 or Kdr). Significantly, deletion of Kdr leads to mucous metaplasia of the intrapulmonary airway epithelium at the early postnatal stage. Furthermore, transiently increased Kdr is required for blocking mucous metaplasia during airway regeneration following naphthalene challenge. Loss of epithelial Kdr or a hypomorphic mutation for the ligand Vegfa leads to abundant mucous cells expressing Sox9 which has been shown to regulate mucous cell differentiation in the intestine. Importantly, mucous metaplasia is also associated with reduced Kdr expression accompanied by increased SOX9 protein levels in ovalbumin (OVA)-induced asthmatic lungs. We therefore hypothesize that Vegf/Kdr signaling is a gatekeeper blocking mucous differentiation of club cell subpopulations during airway regeneration, and that suppressed Kdr promotes mucous metaplasia via Sox9 during asthma pathogenesis. We formulate three specific aims to test the hypothesis. Aim 1: To test the hypothesis that epithelial Kdr blocks club cell differentiation into mucous cells via Erk signaling. Aim 2: To test the hypothesis that Vegfa/Kdr signaling blocks mucous metaplasia of club cell subpopulations. Aim 3: To test the hypothesis that Vegfa/Kdr signaling blocks mucous metaplasia via inhibition of Sox9. Findings from these studies will provide critical insights into the cellular and molecular mechanisms that govern normal mucous cell differentiation and how the mechanism goes awry, leading to mucous metaplasia. Our study will also provide potential therapeutic targets for this common pathological entity.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jianwen Que其他文献

Jianwen Que的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jianwen Que', 18)}}的其他基金

Tuft Cells Modulate Macrophage Response Following Lung Viral Infection
簇细胞调节肺部病毒感染后的巨噬细胞反应
  • 批准号:
    10453066
  • 财政年份:
    2022
  • 资助金额:
    $ 49.18万
  • 项目类别:
The Enrichment Program
强化计划
  • 批准号:
    10612981
  • 财政年份:
    2022
  • 资助金额:
    $ 49.18万
  • 项目类别:
Gastroesophageal junction stem cells as the origin of Barretts esophagus and cancer
胃食管连接处干细胞是巴雷特食管和癌症的起源
  • 批准号:
    10506097
  • 财政年份:
    2022
  • 资助金额:
    $ 49.18万
  • 项目类别:
SOX4-Mediated Transcription Program in Esophageal Adenocarcinoma
SOX4 介导的食管腺癌转录程序
  • 批准号:
    10662315
  • 财政年份:
    2022
  • 资助金额:
    $ 49.18万
  • 项目类别:
Depletion of Barrett's and Esophageal Adenocarcinoma Cells with CRISPR/Cas13d
使用 CRISPR/Cas13d 消除 Barrett 细胞和食管腺癌细胞
  • 批准号:
    10831233
  • 财政年份:
    2022
  • 资助金额:
    $ 49.18万
  • 项目类别:
The Enrichment Program
强化计划
  • 批准号:
    10443140
  • 财政年份:
    2022
  • 资助金额:
    $ 49.18万
  • 项目类别:
SOX4-Mediated Transcription Program in Esophageal Adenocarcinoma
SOX4 介导的食管腺癌转录程序
  • 批准号:
    10407747
  • 财政年份:
    2022
  • 资助金额:
    $ 49.18万
  • 项目类别:
Tuft Cells Modulate Macrophage Response Following Lung Viral Infection
簇细胞调节肺部病毒感染后的巨噬细胞反应
  • 批准号:
    10555330
  • 财政年份:
    2022
  • 资助金额:
    $ 49.18万
  • 项目类别:
Improve Lung Regeneration Through Targeting Tuft Cells Following Viral Infection
通过靶向病毒感染后的簇细胞改善肺再生
  • 批准号:
    10679030
  • 财政年份:
    2021
  • 资助金额:
    $ 49.18万
  • 项目类别:
Improve Lung Regeneration Through Targeting Tuft Cells Following Viral Infection
通过靶向病毒感染后的簇细胞改善肺再生
  • 批准号:
    10471373
  • 财政年份:
    2021
  • 资助金额:
    $ 49.18万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 49.18万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 49.18万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.18万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.18万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 49.18万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.18万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 49.18万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 49.18万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 49.18万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.18万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了